Skip to main contentSkip to navigation
BCLP logo
  • People People

  • SectorsAviation, Aerospace & DefenseEnergy TransitionFinancial InstitutionsFood & AgribusinessHealthcare & Life SciencesReal EstateRetail & Consumer Products Sports, Media & Entertainment

    View all sectors View all sectors

    Practice areasFinanceInvestigationsLitigationReal EstateRegulation, Compliance & AdvisoryTax & Private ClientTransactions

    View all practice areas View all practice areas

  • News News

    AwardsDiversityPro Bono

    View all News View all News

    Insights Insights

    BlogsPodcastsWebinars

    View all Insights View all Insights

  • Perspectives Perspectives

    Getting Deals DoneEmerging Themes 2025The Sustainability Imperative Confronting CorruptionClass Actions
    Trending TopicsArtificial IntelligenceThe Corporate Transparency ActTrump Second Term: Legal Tracker
  • Events Events

    Webinars
  • About us About us

    Pro bono & CommunityInclusion & DiversityResponsible Business

    Client stories Client stories

    Media inquiries Media inquiries

  • Careers
  • Locations
  • Subscribe
BCLP logo
People
Capabilities
News & Insights
BCLP logo

Dr. Frank Miskiel

Frank Miskiel
  1. People

Dr. Frank Miskiel

Dr. Frank Miskiel

Counsel


Irvine
Frank Miskiel
  1. People

Dr. Frank Miskiel

Dr. Frank Miskiel

Counsel


Irvine

Dr. Frank Miskiel

Counsel

Irvine

T: +1 949 223 7127

VcardVcard
Download PDFDownload PDF
Print
Share
  • Biography

  • Resources

Biography

Frank Miskiel, Ph.D., is a highly-experienced intellectual property lawyer focused on patent prosecution in the areas of chemistry, biotechnology, enzymology, pharmaceuticals, industrial, food, cosmetics, household and personal care applications. Dr. Miskiel’s experience includes conducting due diligence for transactions involving IP, inventorship, ownership, scope of protection and enforceability. Dr. Miskiel also has handled many complex and multi-jurisdictional opinions,  freedom to operate analyses and with the preparation of numerous patent decisions in connection with questions related to infringement and invalidity.

Dr. Miskiel has significant experience with food and agriculture, life science, chemical and industrial sectors. This work has included decades of work with hydrocolloids, biologically active compounds and small molecules, therapies including proteins, enzymes, ligands, tumor antigens and carbohydrates. He has also hold wide-ranging fermentation experience, including process optimization, culture development and product recovery. In the life science space, Dr. Miskiel has extensive experience with drug delivery systems, therapeutics, natural gums and hydrocolloids, including their use in molecular gastronomy applications, and rheological modification of systems using natural and synthetic polymers for the food, pharmaceutical, paint, paper, non-wovens, crop protection, oil fields, and personal cosmetic and household care industries.

Prior to his legal career, Dr. Miskiel was a principal scientist for food ingredient leader CP Kelco (now owned by J.M Huber Group) and a research assistant in the Department of Molecular and Cell Biology at Penn State University. Dr. Miskiel is also an inventor on four patents: U.S. Pat. Nos. 6,453,608, 6,290,814, 6,083,890 and 5,342,626.

Admissions

  • California, 2003

  • U.S. Patent & Trademark Office

Education

  • California Western School of Law, J.D., 2002
  • Pennsylvania State University, Ph.D., 1990
  • Pennsylvania State University, B.S., 1985

Related Capabilities

Intellectual Property & Technology Disputes Intellectual Property & Technology Disputes

Litigation & Dispute Resolution Litigation & Dispute Resolution

Regulation, Compliance & Advisory Regulation, Compliance & Advisory

Healthcare & Life Sciences Healthcare & Life Sciences

  • Intellectual Property & Technology Disputes

  • Litigation & Dispute Resolution

  • Regulation, Compliance & Advisory

  • Healthcare & Life Sciences

Resources

Publications

  • "Voluntary labeling of bioengineered food: cognitive dissonance in the law, science, and public policy", California Western Law Review (2001)
  • "A modest proposal to slow rising pharmaceutical prices: abolishing the tax exemption for broadcast, branded, direct-to-consumer advertising", Biotechnology Law Report (2001)
  • "Utilizing cellulon cellulosic fiber for binding in nonwoven applications", TAPPI Journal (1998)

  • "Properties and applications of anti-xanthan antibodies", Carbohydrate Polymers (1995)
  • "The glycoprotein nature and antigenicity of a fungal D-glucosyltransferase", Carbohydrate Research (1986)
  • "The isolation of anti-gum arabic antibodies by affinity chromatography", Journal of Immunological Methods (1986)

Related Insights

News
Jun 28, 2023

BCLP Continues Expansion of IP Group with Additional Team of Four

Related Insights

News
Jun 28, 2023
BCLP Continues Expansion of IP Group with Additional Team of Four
Icon: arrow

Back to top

BCLP logo
  • People
  • Capabilities
  • Practice Areas
  • Sectors
  • News & Insights
  • Awards
  • Blogs
  • News & Events
  • Insights
  • Webinars
  • Perspectives
  • Getting Deals Done
  • Emerging Themes
  • The Sustainability Imperative
  • About us
  • Careers
  • Locations
    • Subscribe
    • Legal notices
    • Privacy notice
    • Modern Slavery Act
    • Cookie policy
    • UK Transparency Rules
    • Media inquiries
    Icon: linkedin

    © 2025 Bryan Cave Leighton Paisner LLP